Evaluation of a new immortalized human fetal liver cell line (cBAL111) for application in bioartificial liver.

BACKGROUND/AIMS Clinical use of bioartificial livers (BAL) relies heavily on the development of human liver cell lines. The aim of this study was to assess the potential of the recently developed human fetal liver cell line cBAL111 for application in the AMC-BAL. METHODS Laboratory-scale AMC-BAL bioreactors were loaded with 20 or 200 million cBAL111 cells and were cultured for 3 days. Parameters for hepatocyte-specific function and general metabolism were determined daily using tests with culture medium or 100% human serum. The bioreactors were also analyzed for mRNA levels of liver-specific genes and histology. RESULTS cBAL111 eliminated ammonia at a rate up to 49% of that in primary porcine hepatocytes (PPH), despite a low (1.1%) urea production. Transcript levels of glutamine synthetase (GS) were 570% of that in human liver, whereas genes of the urea cycle showed low expression. GS expression was confirmed immunohistochemically, and glutamine was produced by the cells. cBAL111 eliminated galactose (90.1% of PPH) and lidocaine (0.1% of PPH) and produced albumin (6% of PPH). Human serum did not increase function of cBAL111. CONCLUSIONS cBAL111 showed liver-specific functionality when cultured inside the AMC-BAL and eliminated ammonia mainly by the activity of GS, and not through the urea cycle.

[1]  R. Costa,et al.  Transcription factors in liver development, differentiation, and regeneration , 2003, Hepatology.

[2]  Yun Wu,et al.  Long term and large-scale cultivation of human hepatoma Hep G2 cells in hollow fiber bioreactor , 1991, Cytotechnology.

[3]  P. Verdonck,et al.  Three-dimensional Numerical Modeling and Computational Fluid Dynamics Simulations to Analyze and Improve Oxygen Availability in the AMC Bioartificial Liver , 2006, Annals of Biomedical Engineering.

[4]  A. Sheil,et al.  Comparison of porcine hepatocytes with human hepatoma (C3A) cells for use in a bioartificial liver support system. , 1998, Cell transplantation.

[5]  J. Seppen,et al.  In Vitro Functionality of Human Fetal Liver Cells and Clonal Derivatives under Proliferative Conditions , 2006, Cell transplantation.

[6]  R. Chamuleau,et al.  Expression of Glutamine Synthetase and Carbamoylphosphate Synthetase I in a Bioartificial Liver: Markers for the Development of Zonation in vitro , 2008, Cells Tissues Organs.

[7]  F. Tronche,et al.  Plasticity and expanding complexity of the hepatic transcription factor network during liver development. , 2006, Genes & development.

[8]  Nicola J. Rinaldi,et al.  Control of Pancreas and Liver Gene Expression by HNF Transcription Factors , 2004, Science.

[9]  P. Soeters,et al.  Fully automated liquid-chromatographic determination of amino acids. , 1988, Clinical chemistry.

[10]  R. Chamuleau,et al.  Time-related analysis of metabolic liver functions, cellular morphology, and gene expression of hepatocytes cultured in the bioartificial liver of the Academic Medical Center in Amsterdam (AMC-BAL). , 2007, Tissue engineering.

[11]  R. Chamuleau,et al.  Assessment and Improvement of Liver Specific Function of the AMC-Bioartificial Liver , 2005, The International journal of artificial organs.

[12]  L. Flendrig,et al.  Evaluation of a novel bioartificial liver in rats with complete liver ischemia: treatment efficacy and species-specific alpha-GST detection to monitor hepatocyte viability. , 1999, Journal of hepatology.

[13]  M V Peshwa,et al.  Primary hepatocytes outperform Hep G2 cells as the source of biotransformation functions in a bioartificial liver. , 1994, Annals of surgery.

[14]  T. Roskams,et al.  The onecut transcription factor HNF6 is required for normal development of the biliary tract. , 2002, Development.

[15]  C. Koike,et al.  Nuclear Receptors CAR and PXR Cross Talk with FOXO1 To Regulate Genes That Encode Drug-Metabolizing and Gluconeogenic Enzymes , 2004, Molecular and Cellular Biology.

[16]  S. Enosawa,et al.  Examination of 7-ethoxycoumarin deethylation and ammonia removal activities in 31 hepatocyte cell lines. , 1996, Cell transplantation.

[17]  J. Park,et al.  Ammonia Removal Using Hepatoma Cells in Mammalian Cell Cultures , 2000, Biotechnology progress.

[18]  P. Poyck,et al.  Increased reproducibility of quantitative reverse transcriptase-PCR. , 2005, Analytical biochemistry.

[19]  C. Selden,et al.  Three‐dimensional in Vitro Cell Culture Leads to a Marked Upregulation of Cell Function in Human Hepatocyte Cell Lines‐an Important Tool for the Development of a Bioartificial Liver Machine , 1999, Annals of the New York Academy of Sciences.

[20]  O. Karlsen,et al.  UvA-DARE ( Digital Academic Repository ) In vitro evaluation of a novel bioreactor based on an integral oxygenator and a spirally wound nonwoven polyester matrix for hepatocyte culture as small aggregates , 2001 .

[21]  Hiroyuki Honda,et al.  Three-dimensional high-density culture of HepG2 cells in a 5-ml radial-flow bioreactor for construction of artificial liver. , 2005, Journal of bioscience and bioengineering.

[22]  Thomas M van Gulik,et al.  Functional and morphological comparison of three primary liver cell types cultured in the AMC bioartificial liver , 2007, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[23]  C. Payne,et al.  Novel immortalized human fetal liver cell line, cBAL111, has the potential to differentiate into functional hepatocytes , 2009, BMC biotechnology.

[24]  C. Selden,et al.  Three Dimensional Culture Upregulates Extracellular Matrix Protein Expression in Human Liver Cell Lines - a Step towards Mimicking the Liver in Vivo? , 2000, The International journal of artificial organs.

[25]  T. Yoshida,et al.  Comparison of different hepatocyte cell lines for use in a hybrid artificial liver model , 1997, Cytotechnology.

[26]  R. Kim,et al.  Human Organic Anion Transporting Polypeptide-C (SLC21A6) Is a Major Determinant of Rifampin-Mediated Pregnane X Receptor Activation , 2003, Journal of Pharmacology and Experimental Therapeutics.

[27]  R. Chamuleau,et al.  Recent Developments on Human Cell Lines for the Bioartificial Liver , 2002, The International journal of artificial organs.

[28]  C Selden,et al.  Human hepatocyte cell lines proliferating as cohesive spheroid colonies in alginate markedly upregulate both synthetic and detoxificatory liver function. , 2001, Journal of hepatology.

[29]  S. Eaton,et al.  Ornithine transcarbamylase and arginase I deficiency are responsible for diminished urea cycle function in the human hepatoblastoma cell line HepG2. , 2007, The international journal of biochemistry & cell biology.